Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

ACE2-binding exposes the SARS-CoV-2 fusion peptide to broadly neutralizing coronavirus antibodies
Jun Siong Low, Josipa Jerak, M. Alejandra Tortorici, et al.
Science (2022) Vol. 377, Iss. 6607, pp. 735-742
Open Access | Times Cited: 138

Showing 1-25 of 138 citing articles:

Broadly neutralizing antibodies to SARS-CoV-2 and other human coronaviruses
Yanjia Chen, Xiaoyu Zhao, Hao Zhou, et al.
Nature reviews. Immunology (2022) Vol. 23, Iss. 3, pp. 189-199
Open Access | Times Cited: 256
The impact of pre-existing cross-reactive immunity on SARS-CoV-2 infection and vaccine responses
Sam M. Murray, M. Azim Ansari, John Frater, et al.
Nature reviews. Immunology (2022) Vol. 23, Iss. 5, pp. 304-316
Open Access | Times Cited: 109
Close relatives of MERS-CoV in bats use ACE2 as their functional receptors
Qing Xiong, Lei Cao, Chengbao Ma, et al.
Nature (2022) Vol. 612, Iss. 7941, pp. 748-757
Open Access | Times Cited: 97
Rational identification of potent and broad sarbecovirus-neutralizing antibody cocktails from SARS convalescents
Yunlong Cao, Fanchong Jian, Zhiying Zhang, et al.
Cell Reports (2022) Vol. 41, Iss. 12, pp. 111845-111845
Open Access | Times Cited: 86
Angiotensin-converting enzyme 2—at the heart of the COVID-19 pandemic
Gavin Y. Oudit, Kaiming Wang, Anissa Viveiros, et al.
Cell (2023) Vol. 186, Iss. 5, pp. 906-922
Open Access | Times Cited: 72
SARS-CoV-2 spike conformation determines plasma neutralizing activity elicited by a wide panel of human vaccines
John E. Bowen, Young‐Jun Park, Cameron Stewart, et al.
Science Immunology (2022) Vol. 7, Iss. 78
Open Access | Times Cited: 67
Identification of a conserved S2 epitope present on spike proteins from all highly pathogenic coronaviruses
Rui P. Silva, Yimin Huang, Annalee W. Nguyen, et al.
eLife (2023) Vol. 12
Open Access | Times Cited: 64
Human neutralizing antibodies to cold linear epitopes and subdomain 1 of the SARS-CoV-2 spike glycoprotein
Filippo Bianchini, Virginia Crivelli, Morgan E. Abernathy, et al.
Science Immunology (2023) Vol. 8, Iss. 81
Open Access | Times Cited: 58
Germline-encoded amino acid–binding motifs drive immunodominant public antibody responses
Ellen Shrock, Richard T. Timms, Tomasz Kula, et al.
Science (2023) Vol. 380, Iss. 6640
Open Access | Times Cited: 54
Cryo-EM structure of SARS-CoV-2 postfusion spike in membrane
Wei Shi, Yongfei Cai, Haisun Zhu, et al.
Nature (2023) Vol. 619, Iss. 7969, pp. 403-409
Open Access | Times Cited: 50
Repeated vaccination of inactivated SARS-CoV-2 vaccine dampens neutralizing antibodies against Omicron variants in breakthrough infection
Bo Gao, Liheng He, Yu-Jie Bao, et al.
Cell Research (2023) Vol. 33, Iss. 3, pp. 258-261
Open Access | Times Cited: 49
Persistent immune imprinting occurs after vaccination with the COVID-19 XBB.1.5 mRNA booster in humans
M. Alejandra Tortorici, Amin Addetia, Albert J. Seo, et al.
Immunity (2024) Vol. 57, Iss. 4, pp. 904-911.e4
Open Access | Times Cited: 45
Functional SARS-CoV-2 cross-reactive CD4 + T cells established in early childhood decline with age
Marion Humbert, Anna Olofsson, David Wullimann, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 12
Open Access | Times Cited: 42
Targetable elements in SARS-CoV-2 S2 subunit for the design of pan-coronavirus fusion inhibitors and vaccines
Liyan Guo, Sheng Lin, Zimin Chen, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 42
Spike deep mutational scanning helps predict success of SARS-CoV-2 clades
Bernadeta Dadonaite, Jack Brown, Teagan E. McMahon, et al.
Nature (2024) Vol. 631, Iss. 8021, pp. 617-626
Open Access | Times Cited: 29
Human coronavirus OC43-elicited CD4+ T cells protect against SARS-CoV-2 in HLA transgenic mice
Rúbens Prince dos Santos Alves, Julia Timis, Robyn Miller, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 12
Clonal analysis of SepSecS-specific B and T cells in autoimmune hepatitis
Michael H. Kramer, Federico Mele, Sandra Jovic, et al.
Journal of Clinical Investigation (2025) Vol. 135, Iss. 2
Closed Access | Times Cited: 1
A variant-proof SARS-CoV-2 vaccine targeting HR1 domain in S2 subunit of spike protein
Wei Pang, Ying Lu, Yan-Bo Zhao, et al.
Cell Research (2022) Vol. 32, Iss. 12, pp. 1068-1085
Open Access | Times Cited: 50
Imprinted antibody responses against SARS-CoV-2 Omicron sublineages
Young‐Jun Park, Dora Pinto, Alexandra C. Walls, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 37
Viral Membrane Fusion: A Dance Between Proteins and Lipids
Judith M. White, Amanda E. Ward, Laura Odongo, et al.
Annual Review of Virology (2023) Vol. 10, Iss. 1, pp. 139-161
Open Access | Times Cited: 35
Broadly neutralizing antibodies against sarbecoviruses generated by immunization of macaques with an AS03-adjuvanted COVID-19 vaccine
Yupeng Feng, Meng Yuan, John M. Powers, et al.
Science Translational Medicine (2023) Vol. 15, Iss. 695
Open Access | Times Cited: 32
SARS-CoV-2 spike S2-specific neutralizing antibodies
Chia‐Jung Li, Shih‐Chung Chang
Emerging Microbes & Infections (2023) Vol. 12, Iss. 2
Open Access | Times Cited: 32
Identification of broad, potent antibodies to functionally constrained regions of SARS-CoV-2 spike following a breakthrough infection
Jamie Guenthoer, Michelle M. Lilly, Tyler N. Starr, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 23
Open Access | Times Cited: 26
Antigenic evolution of SARS coronavirus 2
Anna Z. Mykytyn, Ron A. M. Fouchier, Bart L. Haagmans
Current Opinion in Virology (2023) Vol. 62, pp. 101349-101349
Open Access | Times Cited: 24
Broad-spectrum pan-genus and pan-family virus vaccines
Chee Wah Tan, Sophie Valkenburg, Leo L. M. Poon, et al.
Cell Host & Microbe (2023) Vol. 31, Iss. 6, pp. 902-916
Open Access | Times Cited: 22
Page 1 - Next Page

Scroll to top